Canada markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9680+0.0332 (+3.55%)
At close: 04:00PM EDT
0.9680 0.00 (0.00%)
After hours: 06:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 38.73M
Enterprise Value -7.57M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)186.47
Price/Book (mrq)0.34
Enterprise Value/Revenue -65.85
Enterprise Value/EBITDA 0.35

Trading Information

Stock Price History

Beta (5Y Monthly) 1.43
52-Week Change 3-74.17%
S&P500 52-Week Change 3-2.90%
52 Week High 35.4400
52 Week Low 30.8200
50-Day Moving Average 31.0994
200-Day Moving Average 31.6411

Share Statistics

Avg Vol (3 month) 3143.88k
Avg Vol (10 day) 3101.52k
Shares Outstanding 544.29M
Implied Shares Outstanding 6N/A
Float 833.2M
% Held by Insiders 117.10%
% Held by Institutions 10.42%
Shares Short (Apr 28, 2022) 41.34M
Short Ratio (Apr 28, 2022) 413.01
Short % of Float (Apr 28, 2022) 43.02%
Short % of Shares Outstanding (Apr 28, 2022) 43.02%
Shares Short (prior month Mar 30, 2022) 41.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Aug 30, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-8,368.70%

Management Effectiveness

Return on Assets (ttm)-8.32%
Return on Equity (ttm)-16.91%

Income Statement

Revenue (ttm)115k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)120k
Net Income Avi to Common (ttm)-11.56M
Diluted EPS (ttm)-0.4580
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.33M
Total Cash Per Share (mrq)1.05
Total Debt (mrq)22k
Total Debt/Equity (mrq)0.02
Current Ratio (mrq)16.91
Book Value Per Share (mrq)2.51

Cash Flow Statement

Operating Cash Flow (ttm)-15.85M
Levered Free Cash Flow (ttm)-4.78M